MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Pliant Therapeutics Inc

Geschlossen

1.25 4.17

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.23

Max

1.26

Schlüsselkennzahlen

By Trading Economics

Einkommen

-6.4M

-56M

EPS

-0.92

Angestellte

171

EBITDA

-10M

-59M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+566.67% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-21M

77M

Vorheriger Eröffnungskurs

-2.92

Vorheriger Schlusskurs

1.25

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Pliant Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Juli 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. Juli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Received All Required Authorizations

4. Juli 2025, 15:48 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Agreement Was Announced on Dec. 19

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. Juli 2025, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. Juli 2025, 14:30 UTC

Akquisitionen, Fusionen, Übernahmen

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. Juli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. Juli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

4. Juli 2025, 12:30 UTC

Market Talk

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

4. Juli 2025, 12:15 UTC

Market Talk

Targeted Tariffs Would Likely Support Dollar -- Market Talk

4. Juli 2025, 12:13 UTC

Market Talk

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

4. Juli 2025, 12:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Pliant Therapeutics Inc Prognose

Kursziel

By TipRanks

566.67% Vorteil

12-Monats-Prognose

Durchschnitt 8 USD  566.67%

Hoch 17 USD

Tief 3 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pliant Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

5

Halten

0

Sell

Technischer Score

By Trading Central

1.43 / 1.6Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.